Levin Rami 4
4 · CNS Pharmaceuticals, Inc. · Filed Jan 2, 2026
Insider Transaction Report
Form 4
Levin Rami
DirectorCEO and President
Transactions
- Award
Restricted Stock Units
2026-01-01+19,000→ 19,000 totalExp: 2036-01-01→ Common Stock (19,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Company common stock.
- [F2]The restricted stock units set forth in the table vest as follows: 25% on the six-month anniversary of the transaction date, 25% on the twelve-month anniversary of the transaction date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.
- [F3]Issued in connection with the reporting person's employment with the Company.